FDA Delaying More New Drugs Over Safety

By LINDA A. JOHNSON, AP Business Writer, Medicine & Health / Medications

(AP) -- Under growing scrutiny since the blockbuster painkiller Vioxx was pulled from the market, the Food and Drug Administration in recent months has rejected a slew of experimental drugs or delayed their approval and required more data.

---

Content from The Associated Press expires 15 days after original publication date. For more information about The Associated Press, please visit www.ap.org .

---

» Next Article in Medicine & Health - Medications: Baxter signs British flu vaccine deal